Table 4.
Abridged extractions of rates (events per person-month) and incidence rate ratios (IRRs).
| Event | ePROMa | Control | ePROM/control, IRR (SE; 95% CI) | |||||
| Affordable Better [70]: Colorectal cancer, posttreatment follow-up care (postsurgical) | ||||||||
|
|
Tests/scans | 0.25 | —b | — | ||||
|
|
Parking (90 minutes) | 4×10–3 | — | — | ||||
|
|
Transport | 4×10–3 | — | — | ||||
| CAPRI [37]: Multiple cancers, commencing treatment (oral chemotherapy and/or molecular-targeted therapy) | ||||||||
|
|
Outpatient visits | 4.08 | 4.13 | 0.99 (0.02; 0.95-1.03) | ||||
|
|
Emergency visits | 0.10 | 0.12 | 0.83 (0.12; 0.66-1.05) | ||||
|
|
Hospitalizations | 0.10 | 0.13 | 0.77 (0.12; 0.61-0.97) | ||||
|
|
Trips (1-way) | 1.07 | 1.27 | 0.84 (0.04; 0.78-0.91) | ||||
|
|
|
Ambulance | 0.12 | 0.14 | 0.86 (0.11; 0.69-1.06) | |||
|
|
|
Light sanitary vehicle | 0.26 | 0.35 | 0.74 (0.07; 0.64-0.86) | |||
|
|
|
Taxi | 0.69 | 0.78 | 0.88 (0.05; 0.81-0.97) | |||
|
|
Death (adjusted HRc) | — | — | 1.16 (0.17; 0.83-1.61) | ||||
| eRAPID [4,90]: Multiple cancers, commencing treatment | ||||||||
|
|
ePROM-triggered alerts | 3.45 | — | — | ||||
|
|
|
No problems (no alert) | 0.11 | — | — | |||
|
|
|
Moderate (self-management) | 2.83 | — | — | |||
|
|
|
Severe (prompt to contact HCPsd) | 0.48 | — | — | |||
|
|
|
Emergency (alerts HCPs) | 0.03 | — | — | |||
| PROMPT-Care [5]: Multiple cancers, active treatment or posttreatment follow-up care | ||||||||
|
|
Emergency visits | 0.05 | 0.06 | 0.87 (0.06; 0.77-0.98) | ||||
|
|
ePROM-triggered alerts | 0.14 | — | — | ||||
| Sentinel [34,35]: Lung cancer, active treatment or posttreatment follow-up care | ||||||||
|
|
Consultations | 0.31 | 0.22 | 1.38 (0.11; 1.11-1.72) | ||||
|
|
Imaging tests | 0.26 | 0.27 | 0.96 (0.11; 0.77-1.19) | ||||
|
|
Trips (round) | 0.41 | 0.29 | 1.41 (0.10; 1.17-1.72) | ||||
|
|
|
Ambulance | 3×10–3 | 0.02 | 0.17 (0.77; 0.04-0.78) | |||
|
|
|
LSVe/taxi | 0.19 | 0.16 | 1.21 (0.14; 0.93-1.59) | |||
|
|
|
Private vehicle | 0.19 | 0.11 | 1.73 (0.15; 1.28-2.34) | |||
|
|
|
Public transport | 0.03 | 0 | — | |||
|
|
|
On foot | 0 | 3×10–3 | — | |||
|
|
Death (adjusted HR) | — | — | 0.32 ± 0.38 (0.15, 0.67) | ||||
| SIS.NET [83]: Breast cancer, posttreatment follow-up care (fully recovered from all acute serious side effects) | ||||||||
|
|
Physician visits | 0.60 | 0.53 | 1.13 | ||||
|
|
Tests/scans | 0.30 | 0.28 | 1.08 | ||||
|
|
|
Breast cancer-related | 0.21 | 0.21 | 0.99 | |||
|
|
|
Non–breast cancer | 0.11 | 0.07 | 1.56 | |||
|
|
Symptom reports | 0.41 | 0.18 | 2.30 | ||||
| STARf [38]: Solid cancers, active treatment, mean (95% CI) | ||||||||
|
|
Death (adjusted rate) | 0.024 (0.020-0.029) | 0.031 (0.026-0.038) | N/Ag | ||||
|
|
Computer inexperienced | 0.043 (0.028-0.062) | 0.043 (0.028-0.062) | N/A | ||||
|
|
Computer experienced | 0.028 (0.022-0.036) | 0.028 (0.022-0.036) | N/A | ||||
aePROM: electronic patient-reported outcome measures.
bNot available.
cHR: hazard ratio.
dHCP: health care professional.
eLSV: light sanitary vehicle (non-ambulance medical transport).
fSTAR: Symptom Tracking and Reporting.
gN/A: not applicable.